IC
GILD icon

IKOS CIF’s Gilead Sciences GILD Stock Holding History

IKOS CIF’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$79K Buy
+1,000
New +$81.2K 0.47% 55
2016
Q2 		– Sell
-2,556
Closed -$236K – 164
2016
Q1 		$236K Sell
2,556
-1,695
-40% -$153K 0.58% 71
2015
Q4 		$434K Buy
4,251
+2,842
+202% +$296K 1.33% 8
2015
Q3 		$138K Sell
1,409
-1,631
-54% -$181K 0.4% 124
2015
Q2 		$356K Buy
+3,040
New +$332K 1.17% 1

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IKOS CIF's GILD Position: Q3 2016 in Review

IKOS CIF opened a new position in Gilead Sciences (GILD) in Q3 2016: 1,000 shares worth $79K. The stake represents 0.47% of the portfolio and ranks #55 among its holdings. This is a return to the name: IKOS CIF previously reported a position in GILD as recently as Q1 2016.

IKOS CIF first reported a position in GILD in Q2 2015 and has held it in 5 quarters since. The position peaked at $434K in Q4 2015. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • IKOS CIF held 1,000 shares of Gilead Sciences worth $79K as of Q3 2016.
  • Gilead Sciences was a new IKOS CIF position in Q3 2016.
  • Gilead Sciences made up 0.47% of IKOS CIF's portfolio in Q3 2016, its #55 holding.
  • IKOS CIF first reported a position in Gilead Sciences in Q2 2015 and has held it in 5 quarters since.
  • IKOS CIF's Gilead Sciences position peaked at $434K in Q4 2015.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on IKOS CIF's 13F filing for Q3 2016, filed 10 Nov 2016.